KELLY TAIS AZAMBUJA CACHOEIRA: Open Payments
NPI 1295599900 · BANNOCKBURN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,672 in 51 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,046 · 2025 $1,672
Food & beverage: $1,672
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $326 |
| Novartis Pharmaceuticals Corporation | 13 | $287 |
| Novo Nordisk Inc | 5 | $271 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $203 |
| BridgeBio Pharma, Inc. | 3 | $170 |
| Amgen Inc. | 2 | $135 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $51 |
| PFIZER INC. | 2 | $51 |
| Abbott Laboratories | 2 | $43 |
| Ionis Pharmaceuticals, Inc. | 1 | $24 |
Products named: LEQVIO, JARDIANCE, Attruby, Wegovy, FARXIGA, REPATHA, LOKELMA, Ozempic.
Industry payments across IL — which companies pay providers there.
